GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma A Phase II Study of the Fondazione Italiana Linfomi (FIL)
Latest Information Update: 23 May 2023
Price :
$35 *
At a glance
- Drugs Obinutuzumab (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Therapeutic Use
- Acronyms FIL_GAEL
- 13 Aug 2021 This trial has been completed in Italy, according to European Clinical Trials Database record.
- 04 Nov 2020 Status changed from suspended to discontinued.
- 29 Nov 2017 Status changed from recruiting to suspended.